StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$58.65+0.77 (+1.33%)

Close on Nov 18, 2026Market cap $3.00BP/E 139.6Yield –

Vericel free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Vericel's free cash flow for the twelve months ending Jun 30, 2026 was $61.66M. For fiscal 2025 it was $24.75M. The highest annual figure on record is $24.75M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.75M–
FY2024Dec 31, 2024-$5.81M-138.0%
FY2023Dec 31, 2023$15.30M+51.6%
FY2022Dec 31, 2022$10.09M-52.2%
FY2021Dec 31, 2021$21.13M+41.3%
FY2020Dec 31, 2020$14.95M–
FY2019Dec 31, 2019-$9.80M–
FY2018Dec 31, 2018-$3.09M–
FY2017Dec 31, 2017-$14.69M–
FY2016Dec 31, 2016-$21.31M–
FY2015Dec 31, 2015-$15.77M–
FY2014Dec 31, 2014-$26.24M–
FY2013Dec 31, 2013-$19.98M–
FY2012Dec 31, 2012-$29.82M–
FY2010Jun 30, 2010-$15.21M–
FY2009Jun 30, 2009-$13.84M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.26M+17503.7%
Q1 FY2026Mar 31, 2026$15.13M–
Q4 FY2025Dec 31, 2025$12.83M+51.7%
Q3 FY2025Sep 30, 2025$19.45M–
Q2 FY2025Jun 30, 2025$81.00K-95.4%
Q1 FY2025Mar 31, 2025-$7.61M–
Q4 FY2024Dec 31, 2024$8.46M+275.6%
Q3 FY2024Sep 30, 2024-$9.23M-1637.5%
Q2 FY2024Jun 30, 2024$1.77M-70.4%
Q1 FY2024Mar 31, 2024-$6.82M-205.7%
Q4 FY2023Dec 31, 2023$2.25M-61.5%
Q3 FY2023Sep 30, 2023$600.00K-77.7%
Q2 FY2023Jun 30, 2023$6.00M+416.4%
Q1 FY2023Mar 31, 2023$6.45M+1565.9%
Q4 FY2022Dec 31, 2022$5.85M-38.8%
Q3 FY2022Sep 30, 2022$2.69M+129.9%
Q2 FY2022Jun 30, 2022$1.16M-56.2%
Q1 FY2022Mar 31, 2022$387.00K-95.0%
Q4 FY2021Dec 31, 2021$9.56M-6.9%
Q3 FY2021Sep 30, 2021$1.17M-72.1%
Q2 FY2021Jun 30, 2021$2.65M–
Q1 FY2021Mar 31, 2021$7.74M+95.1%
Q4 FY2020Dec 31, 2020$10.27M+268.1%
Q3 FY2020Sep 30, 2020$4.20M-38.8%
Q2 FY2020Jun 30, 2020-$3.49M–
Q1 FY2020Mar 31, 2020$3.97M–
Q4 FY2019Dec 31, 2019$2.79M+37.1%
Q3 FY2019Sep 30, 2019$6.86M+670.0%
Q2 FY2019Jun 30, 2019-$19.37M–
Q1 FY2019Mar 31, 2019-$78.00K-135.3%
Q4 FY2018Dec 31, 2018$2.03M+1653.4%
Q3 FY2018Sep 30, 2018$891.00K–
Q2 FY2018Jun 30, 2018-$6.24M–
Q1 FY2018Mar 31, 2018$221.00K–
Q4 FY2017Dec 31, 2017$116.00K–

More Vericel figures

See a number that looks wrong?